Harvard Neuropsychiatry: A Comprehensive Update 2023 
Digestive Disease Week 2022 
This CME activity brings together some of our most popular lectures in PET and PET/CT imaging. Basic to advanced applications of PET and PET/CT are put in the context of disease detection and treatment planning. Faculty share techniques, tips and pitfalls through case based presentations.
Educational Objectives
At the completion of this CME teaching activity, you should be able to:
- Apply state-of-the-art protocols to evaluate neurodegenerative disease, head and neck and cutaneous cancers to clinical practice.
- Implement newer protocols for evaluating cancers of the lung, prostate, breast and female pelvis into practice.
- Optimize PET and PET/CT imaging protocols for the detection and follow up of lymphoma and musculoskeletal tumors.
- Describe the advantages and pitfalls of PET and PET/CT.
- Differentiate normal variants and urgent findings on PET/CT.
- Discuss the utility of PET/CT when used to evaluate cardiac disease, gastrointestinal, thyroid and prostate cancers.
Target Audience
This CME activity should benefit radiologists, oncologists, and nuclear medicine physicians. The course should also prove valuable for physicians who order these studies.
Program
PET/CT Techniques and Reporting Principles
Eric M. Rohren, M.D., Ph.D.
Evaluation of Neurodegenerative Diseases and Seizures
Jonathan McConathy, M.D., Ph.D.
PET/CT for Neurodegenerative Diseases
Gagandeep Choudhary, M.D.
PET/CT in Lymphomas
Mark Tulchinsky, M.D., FACNM
PET/CT in Head and Neck Cancer
Don C. Yoo, M.D.
PET/CT in Malignancy of the Breast and Female Pelvis
Charito Love, M.D.
PET/CT for Non-Neurodegenerative Diseases
Gagandeep Choudhary, M.D.
PET/CT in Thyroid Cancer
Mark Tulchinsky, M.D., FACNM
PET/CT in Malignancy of Female Breast and Pelvis
Katherine Zukotynski, M.D.
PET/CT in Cancers of the Skin
Mark Tulchinsky, M.D., FACNM
PET/CT in Gastrointestinal Malignancies
Eric M. Rohren, M.D., Ph.D.
PET/CT in Infection and Inflammation Imaging
Don C. Yoo, M.D.
Qualitative and Quantitative Response Criteria
Eric M. Rohren, M.D., Ph.D.
PET/CT in Malignancy of the Lung
Don C. Yoo, M.D.
PET/CT in Metastatic Skeletal Disease and Primary Tumors
Charito Love, M.D.
PET/CT in Skeletal Tumors: Primary and Metastatic
Katherine Zukotynski, M.D.
Growing PET/CT Referrals
Eric M. Rohren, M.D., Ph.D.
CME Release Date 10/15/2024
CME Expiration Date 10/14/2024
